CClinicalTrials.gg
RecruitingNCT07190339Updated Sep 30, 2025

Femoral and Obturator Nerve Articular Branches Prf

An interventional study of ultrasound-guided femoral and obturator nerve articular branches pulsed radiofrequency in Hip Ostearthritis, sponsored by Diskapi Teaching and Research Hospital. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2025-09-30.

Sponsored by Diskapi Teaching and Research Hospital · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Apr 2026, 5 months ago, but the record still lists the study as recruiting.
  • Started Sep 2025; still recruiting 1 year later.
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Not applicable
Ages
18 Years to 75 Years
Sex
All
01

Study summary

In our clinic, patients undergoing pulsed radiofrequency treatment of the femoral and obturator nerve articular branches under ultrasound guidance for pain management due to hip and groin pain associated with hip osteoarthritis will have the efficacy of these methods on pain compared with the Numeric Rating Scale (NRS) and Oxford Hip Score (OHS) at 2, 6, 12 weeks.

Read the detailed description

Osteoarthritis of the hip joint is a common cause of pain and disability. Patients who do not respond to conservative treatments such as painkillers, physical therapy, and exercise often cannot undergo joint replacement due to comorbid conditions, while some patients prefer to postpone surgery as long as possible. Pulsed radiofrequency treatment applied to the articular branches of the femoral and obturator nerves, which innervate the joint, is a new technique for reducing hip joint pain. Previous studies have reported positive results after applying thermal neurolytic radiofrequency to the target nerves; however, this approach carries the risk of neuritis and neuroma formation. In our study, we aimed to investigate the effectiveness of pRF treatment applied to the articular branches of the femoral and obturator nerves under ultrasound guidance on pain and functionality in patients with chronic hip pain associated with osteoarthritis. The fact that the procedure is performed under ultrasound guidance, does not involve radiation exposure, and is an accessible and easy-to-perform technique makes it preferable for both patients and physicians.

02

Conditions studied

  • Hip Ostearthritis

Keywords

  • Pulsed Radiofrequency Treatment
  • Ultrasonography
  • femoral and obturator nerve articular branches
03

In context

Lead sponsor

Diskapi Teaching and Research Hospital is the lead sponsor of 101 studies on the registry; 13 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • 1. Patients with hip and groin pain who have been diagnosed with hip osteoarthritis by direct radiography
  • 2. Patients who have had hip pain above VAS 5 for more than 6 weeks
  • 3. Failure of pain treatment with conservative methods such as analgesics and physical therapy

Exclusion criteria

Exclusion Criteria:

  • 1. Patients with lumbar radiculopathy and axial back pain, sacroiliac joint, connective tissue disease
  • 2. Patients who do not attend follow-up appointments regularly or cannot be reached by phone
  • 3. Patients who started additional analgesic medication or underwent additional interventional procedures after the initial interventional procedure
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Other
    pulsed radiofrequency group

    femoral and obturator nerve articular branches pulsed radiofrequency for hip osteoartritis

    Procedure: ultrasound-guided femoral and obturator nerve articular branches pulsed radiofrequency

Interventions

  • Procedureultrasound-guided femoral and obturator nerve articular branches pulsed radiofrequency

    Hemodynamic monitoring is provided. The hip joint where the procedure will be performed is cleaned with povidone-iodine. Sterile draping is performed. For PRF application to the articular branches of the femoral nerve, a convex ultrasound probe is first used to locate the articular branches of the femoral nerve in the groin area, followed by the articular branches of the obturator nerve. The radiofrequency cannula is inserted sequentially into the target points and sensory feedback is obtained. Then, a pulsed radiofrequency current, which has therapeutic properties for chronic pain and does not damage tissues by exceeding a temperature of 42 degrees, is applied to the relevant nerve root for 240 seconds. Subsequently, an injectate consisting of 2 cc of 5% bupivacaine, 4 mg of dexamethasone, and 2 cc of physiological saline is administered to the same nerve. Translated with DeepL.com (free version)

06

What researchers measure

Primary outcomes

  1. numeric rating scale

    The numeric rating scale (NRS) is a pain screening tool, commonly used to assess pain severity at that moment in time using a 0-10 scale, with zero meaning "no pain" and 10 meaning "the worst pain imaginable"

    Time frame: Change from baseline to 2nd 6 th and 12th weeks after treatment

Secondary outcomes

  1. oxford hip score

    The Oxford Hip Score (OHS) is a joint-specific, patient-reported outcome measure designed to assess disability in patients witth hip osteoarthritis

    Time frame: Change from baseline to 2nd 6th and 12th weeks after treatment

07

Study locations

1 of 1 sites recruiting
  • Ankara Etlik City Hospital
    Ankara, Turkey (Türkiye)
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 30, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07190339
Lead sponsor
Diskapi Teaching and Research Hospital
Responsible party
Damla Yürük (Supervisor Investigator, Diskapi Teaching and Research Hospital) — Principal investigator
First posted
Sep 24, 2025
Start date
Sep 20, 2025
Primary completion
Apr 20, 2026 (estimated)
Completion
Aug 20, 2026 (estimated)
Last update
Sep 30, 2025

Study contacts

Emine Yuksel, TR
Contact
eminecan_02@hotmail.com
+905453489378
Gevher Rabia Genc Perdecioglu, TR
Contact
gevhergenc@gmail.com
+905332009184
Gevher Rabia Genc Perdecioğlu
study chair · Diskapi TRH

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion